Tim Buckley Elected to Pfizer’s Board of Directors

For the past five months, Pfizer has been conducting a comprehensive search for a new member of our Board of Directors. Today we are happy to announce that Tim Buckley, a widely respected business leader with deep expertise in global investment management, financial markets, and operations, has been elected as the 14th member, effective immediately.

Mr. Buckley has a lengthy and impressive resume, including more than 30 years at Vanguard, where he held numerous senior leadership roles and served as Chairman and CEO from 2018 until his retirement earlier this year. He also previously served as Chairman of the Board of Children’s Hospital of Philadelphia from 2011 to 2017.

“We are pleased to welcome Tim Buckley to Pfizer’s Board of Directors,” stated Albert Bourla, Pfizer Chairman and Chief Executive Officer. “Tim is a widely respected business leader with deep expertise in global investment management, financial markets, and operations, and someone who values a shared sense of purpose, all of which will be an asset to Pfizer and our shareholders.”

Concurrent with his appointment to the Board of Directors, Mr. Buckley also joins both the Governance and Sustainability Committee and the Audit Committee of Pfizer’s Board.

Get more details about the news in the press release Pfizer issued earlier today.